3 Experts Have Resigned From An FDA Committee Over Alzheimer's Drug Approval

In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.